Income Taxes - Additional Information (Detail) - USD ($)
|
|
12 Months Ended |
|
|
Jun. 29, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 27, 2020 |
Dec. 31, 2019 |
| Income Tax Contingency [Line Items] |
|
|
|
|
|
| Deferred provision for income taxes |
|
$ 0
|
$ 0
|
|
|
| Increase in valuation allowance |
|
$ 35,200,000
|
29,700,000
|
|
|
| Deferred tax assets net operating loss carryforwards ownership change in percentage |
|
50.00%
|
|
|
|
| Offset percentage of taxable income |
|
80.00%
|
|
|
|
| Unrecognized tax benefits, income tax penalties and interest expense |
|
$ 0
|
0
|
|
|
| Unrecognized tax benefits |
|
2,441,000
|
$ 1,536,000
|
|
$ 637,000
|
| Impact of CARES Act to Income Taxes |
|
0
|
|
|
|
| Suspension period |
3 years
|
|
|
|
|
| Cap period |
3 years
|
|
|
|
|
| Incentive tax credits offset amount of tax |
$ 5,000,000
|
|
|
|
|
| Taxable income |
$ 1,000,000
|
|
|
|
|
| CAA impact to tax provision |
|
|
|
$ 0
|
|
| Uncertain tax positions related to liability |
|
0
|
|
|
|
| Australia |
|
|
|
|
|
| Income Tax Contingency [Line Items] |
|
|
|
|
|
| Net operating loss carryforwards |
|
1,500,000
|
|
|
|
| Federal [Member] |
|
|
|
|
|
| Income Tax Contingency [Line Items] |
|
|
|
|
|
| Net operating loss carryforwards |
|
$ 255,900,000
|
|
|
|
| Deferred tax assets net operating loss carryforwards expiration year |
|
2038
|
|
|
|
| Deferred tax assets, research and development tax credit carryforwards |
|
$ 6,100,000
|
|
|
|
| Tax credit research and development carryforward expiration year |
|
2038
|
|
|
|
| State [Member] |
|
|
|
|
|
| Income Tax Contingency [Line Items] |
|
|
|
|
|
| Net operating loss carryforwards |
|
$ 263,000,000.0
|
|
|
|
| Deferred tax assets, research and development tax credit carryforwards |
|
$ 3,000,000.0
|
|
|
|